UPLOAD Filing
HERON THERAPEUTICS, INC. /DE/
Date: Sept. 11, 2025 · CIK: 0000818033 · Accession: 0000000000-25-009896
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290142
Letter
Re: Heron Therapeutics, Inc. Registration Statement on Form S-3 Filed September 9, 2025 File No. 333-290142 Dear Craig Collard:
September 11, 2025
Craig Collard Chief Executive Officer Heron Therapeutics, Inc. 100 Regency Forest Drive, Suite 300 Cary, North Carolina 27518
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Emilio Ragosa, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 11, 2025 Craig Collard Chief Executive Officer Heron Therapeutics, Inc. 100 Regency Forest Drive, Suite 300 Cary, North Carolina 27518 Re: Heron Therapeutics, Inc. Registration Statement on Form S-3 Filed September 9, 2025 File No. 333-290142 Dear Craig Collard: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Emilio Ragosa, Esq. </TEXT> </DOCUMENT>